Get started
Author

Tory V. Kaye

Observed name: Tory Kaye
Observed institution: Minnesota Department of Health
OpenAlex ID: A5073723246
Notes from the Field: Universal Newborn Screening and Surveillance for Congenital Cytomegalovirus — Minnesota, 2023–2024
2024 · Tory Kaye, Elizabeth M. Dufort, et al. · MMWR Morbidity and Mortality Weekly Report · 35
PDF
Prognostication and Biomarker Potential of C26:0 Lysophosphatidylcholine in Adrenoleukodystrophy
2025 · Charles J. Billington, Arpana Rayannavar, et al. · Archives of Pediatrics and Adolescent Medicine · 16
Disparities in late and lost: Pediatricians' role in following Pompe disease identified by newborn screening
2023 · Nishitha R. Pillai, Noelle Andrea V. Fabie, et al. · Molecular Genetics and Metabolism · 7
Insights From Minnesota on Newborn Screening for Adrenoleukodystrophy: A 5‐Year Update
2025 · Arpana Rayannavar, Charles J. Billington, et al. · American Journal of Medical Genetics Part A · 4
When follow-up falls short: A case series on infants lost in newborn screening follow-up for mucopolysaccharidosis type I
2026 · Tory Kaye, Karissa Tricas, et al. · Molecular Genetics and Metabolism
Newborn screening experience and outcome from a Minnesota Pompe disease consortium
2022 · Nishitha R. Pillai, Noelle A.V. Fabie, et al. · Molecular Genetics and Metabolism
Works count: 6
Citation count: 61
H-index: 4
I10-index: 2
Year
Topic
Type